GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » Cyclically Adjusted PB Ratio

SK Biopharmaceuticals Co (XKRX:326030) Cyclically Adjusted PB Ratio : 25.17 (As of Jun. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co Cyclically Adjusted PB Ratio?

As of today (2024-06-08), SK Biopharmaceuticals Co's current share price is ₩86200.00. SK Biopharmaceuticals Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was ₩3,424.63. SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio for today is 25.17.

The historical rank and industry rank for SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:326030' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 17.93   Med: 26.85   Max: 51.07
Current: 24.94

During the past 13 years, SK Biopharmaceuticals Co's highest Cyclically Adjusted PB Ratio was 51.07. The lowest was 17.93. And the median was 26.85.

XKRX:326030's Cyclically Adjusted PB Ratio is ranked worse than
97.58% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs XKRX:326030: 24.94

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SK Biopharmaceuticals Co's adjusted book value per share data of for the fiscal year that ended in Dec23 was ₩3,622.459. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩3,424.63 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


SK Biopharmaceuticals Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Biopharmaceuticals Co Cyclically Adjusted PB Ratio Chart

SK Biopharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 51.07 28.75 21.16 29.32

SK Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 29.32 -

Competitive Comparison of SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.



SK Biopharmaceuticals Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=86200.00/3424.63
=25.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SK Biopharmaceuticals Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, SK Biopharmaceuticals Co's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=3622.459/118.8477*118.8477
=3,622.459

Current CPI (Dec23) = 118.8477.

SK Biopharmaceuticals Co Annual Data

Book Value per Share CPI Adj_Book
201412 4,376.499 99.098 5,248.712
201512 3,564.856 100.220 4,227.449
201612 2,952.682 101.560 3,455.292
201712 944.855 102.990 1,090.337
201812 942.077 104.350 1,072.963
201912 -200.333 105.120 -226.495
202012 4,840.392 105.765 5,439.108
202112 5,671.936 109.676 6,146.232
202212 4,042.236 115.200 4,170.222
202312 3,622.459 118.848 3,622.459

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SK Biopharmaceuticals Co  (XKRX:326030) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


SK Biopharmaceuticals Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of SK Biopharmaceuticals Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SK Biopharmaceuticals Co (XKRX:326030) Business Description

Traded in Other Exchanges
N/A
Address
221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

SK Biopharmaceuticals Co (XKRX:326030) Headlines

No Headlines